2023 Q2 Form 10-Q Financial Statement

#000078332423000031 Filed on April 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $878.0K $1.168M $711.0K
YoY Change 0.23% -16.63% -19.3%
% of Gross Profit
Research & Development $682.0K $804.0K $833.0K
YoY Change -30.69% -55.06% -56.97%
% of Gross Profit
Depreciation & Amortization $10.00K $10.00K $11.00K
YoY Change 0.0% -28.57% -15.38%
% of Gross Profit
Operating Expenses $1.570M $1.982M $1.555M
YoY Change -16.04% 517.45% -45.05%
Operating Profit
YoY Change
Interest Expense $70.00K $69.00K $64.00K
YoY Change 677.78% 6800.0% 966.67%
% of Operating Profit
Other Income/Expense, Net $67.00K $11.00K -$4.000K
YoY Change -84.98% 1000.0% -150.0%
Pretax Income -$1.503M -$1.971M -$1.495M
YoY Change 5.55% 515.94% -82.02%
Income Tax
% Of Pretax Income
Net Earnings -$1.503M -$1.971M -$1.495M
YoY Change 5.55% 515.94% -82.02%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.02
Diluted Earnings Per Share -$0.01 -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 119.8M 119.0M 118.3M
Diluted Shares Outstanding 120.6M 119.0M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.986M $6.645M $8.110M
YoY Change -45.93% -48.32% -38.28%
Cash & Equivalents $5.986M $6.645M $8.110M
Short-Term Investments $0.00
Other Short-Term Assets $342.0K $446.0K $537.0K
YoY Change -18.76% -32.73% -33.79%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $6.328M $7.091M $8.647M
YoY Change -44.93% -47.55% -38.02%
LONG-TERM ASSETS
Property, Plant & Equipment $173.0K $183.0K $193.0K
YoY Change -19.16% -18.3% -17.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.319M $2.329M $2.339M
YoY Change -1.9% -2.06% -2.17%
TOTAL ASSETS
Total Short-Term Assets $6.328M $7.091M $8.647M
Total Long-Term Assets $2.319M $2.329M $2.339M
Total Assets $8.647M $9.420M $10.99M
YoY Change -37.59% -40.75% -32.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.00K $218.0K $169.0K
YoY Change -73.68% -69.81% -70.14%
Accrued Expenses $703.0K $621.0K $764.0K
YoY Change -13.95% -24.27% -8.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $758.0K $839.0K $933.0K
YoY Change -26.12% -45.59% -47.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $36.00K $33.00K $24.00K
YoY Change 33.33% 32.0% 14.29%
Total Long-Term Liabilities $36.00K $33.00K $24.00K
YoY Change 33.33% -87.55% -90.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $758.0K $839.0K $933.0K
Total Long-Term Liabilities $36.00K $33.00K $24.00K
Total Liabilities $794.0K $872.0K $957.0K
YoY Change -24.6% -51.74% -53.29%
SHAREHOLDERS EQUITY
Retained Earnings -$468.3M -$466.8M -$464.8M
YoY Change 1.44% 1.43% 1.07%
Common Stock $476.1M $475.3M $474.8M
YoY Change 0.36% 0.22% 0.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.853M $8.548M $10.03M
YoY Change
Total Liabilities & Shareholders Equity $8.647M $9.420M $10.99M
YoY Change -37.59% -40.75% -32.78%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$1.503M -$1.971M -$1.495M
YoY Change 5.55% 515.94% -82.02%
Depreciation, Depletion And Amortization $10.00K $10.00K $11.00K
YoY Change 0.0% -28.57% -15.38%
Cash From Operating Activities -$1.219M -$1.776M -$1.663M
YoY Change -32.28% -27.57% -47.74%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $453.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 560.0K 311.0K 193.0K
YoY Change 2334.78% -195.11%
NET CHANGE
Cash From Operating Activities -1.219M -1.776M -1.663M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 560.0K 311.0K 193.0K
Net Change In Cash -659.0K -1.465M -1.470M
YoY Change -63.14% 436.63% -54.92%
FREE CASH FLOW
Cash From Operating Activities -$1.219M -$1.776M -$1.663M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$1.219M -$1.776M -$1.663M
YoY Change -32.28% -27.72% -47.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24000
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000783324
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-9025
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
33000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
24000
CY2023Q1 us-gaap Liabilities
Liabilities
872000
CY2022Q4 us-gaap Liabilities
Liabilities
957000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119727572
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
118480878
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
475337000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
667000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.67
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
474847000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-466789000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-464818000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8548000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10029000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9420000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10986000
CY2022Q1 vgz Gain Loss On Disposal Of Mineral Property Interests Net
GainLossOnDisposalOfMineralPropertyInterestsNet
2883000
CY2023Q1 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
804000
CY2022Q1 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
1789000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1168000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1401000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1982000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
321000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
69000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-58000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1971000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-320000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1971000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-320000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119041318
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117444389
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119041318
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117444389
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14294000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-327000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
444000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-320000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
14091000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10029000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
453000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-142000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
179000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1971000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8548000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1971000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-320000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
179000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
444000
CY2022Q1 vgz Gain Loss On Disposal Of Mineral Property Interests Net
GainLossOnDisposalOfMineralPropertyInterestsNet
2883000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-91000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-148000
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
VISTA GOLD CORP.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0542444
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
7961 Shaffer Parkway, Suite 5
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Littleton
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80127
CY2023Q1 dei City Area Code
CityAreaCode
720
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
981-1185
CY2023Q1 dei Security12b Title
Security12bTitle
Common Shares, no par value
CY2023Q1 dei Trading Symbol
TradingSymbol
VGZ
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-85000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
145000
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119827572
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6645000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8110000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
446000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
537000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
7091000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8647000
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
2146000
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
2146000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193000
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
2329000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2339000
CY2023Q1 us-gaap Assets
Assets
9420000
CY2022Q4 us-gaap Assets
Assets
10986000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
218000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
169000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
621000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
764000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
839000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
933000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1776000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2452000
CY2022Q1 us-gaap Payments For Proceeds From Heldtomaturity Securities Shortterm
PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm
-11000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
2500000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2506000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
453000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
142000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
327000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
311000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-327000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1465000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-273000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8110000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12757000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6645000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12484000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y7M20D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
38000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1367000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y7M20D
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5697000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5514000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5697000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5504000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193000
CY2023Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
96000
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
112000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
481000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
614000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
38000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
621000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
764000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
700000
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.75
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
667000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.67
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y10M9D
CY2023Q1 vgz Percentage Of Issued And Outstanding Common Shares For Stock Based Compensation Plan
PercentageOfIssuedAndOutstandingCommonSharesForStockBasedCompensationPlan
0.10
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
444000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1367000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y10M9D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0

Files In Submission

Name View Source Status
vgz-20230331_cal.xml Edgar Link unprocessable
vgz-20230331_lab.xml Edgar Link unprocessable
0000783324-23-000031-index-headers.html Edgar Link pending
0000783324-23-000031-index.html Edgar Link pending
0000783324-23-000031.txt Edgar Link pending
0000783324-23-000031-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vgz-20230331.xsd Edgar Link pending
vgz-20230331x10q.htm Edgar Link pending
vgz-20230331x10q001.jpg Edgar Link pending
vgz-20230331xex23d1.htm Edgar Link pending
vgz-20230331xex23d2.htm Edgar Link pending
vgz-20230331xex23d3.htm Edgar Link pending
vgz-20230331xex23d4.htm Edgar Link pending
vgz-20230331xex31d1.htm Edgar Link pending
vgz-20230331xex31d2.htm Edgar Link pending
vgz-20230331xex32d1.htm Edgar Link pending
vgz-20230331xex32d2.htm Edgar Link pending
vgz-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
vgz-20230331_pre.xml Edgar Link unprocessable
vgz-20230331x10q_htm.xml Edgar Link completed